Global Companion Diagnostics Market Research Report 2024(Status and Outlook)

Global Companion Diagnostics Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Companion Diagnostics Market Size was estimated at USD 4575.83 million in 2023 and is projected to reach USD 9628.28 million by 2029, exhibiting a CAGR of 13.20% during the forecast period.

This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics market in any manner.

Global Companion Diagnostics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Roche Holdings

Abbott Laboratories

Thermo Fisher Scientific

Agilent Technologies

Life Technologies

GE Healthcare

Agendia

Qiagen

Genomic Health

Myriad Genetics

Advanced Cell Diagnostics

Danaher

Applied Proteomics

Market Segmentation (by Type)

Polymerase Chain Reaction (PCR)

Immunohistochemistry (IHC)

In Situ Hybridization (ISH)

Next Generation Sequencing (NGS)

Market Segmentation (by Application)

Hospitals

Pharmaceutical Companies

Laboratories

Other

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Companion Diagnostics Market
  • Overview of the regional outlook of the Companion Diagnostics Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Companion Diagnostics
1.2 Key Market Segments
1.2.1 Companion Diagnostics Segment by Type
1.2.2 Companion Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Companion Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Companion Diagnostics Market Competitive Landscape
3.1 Global Companion Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostics Sales Sites, Area Served, Product Type
3.6 Companion Diagnostics Market Competitive Situation and Trends
3.6.1 Companion Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Companion Diagnostics Industry Chain Analysis
4.1 Companion Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Companion Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Companion Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostics Price by Type (2019-2024)
7 Companion Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
8 Companion Diagnostics Market Segmentation by Region
8.1 Global Companion Diagnostics Sales by Region
8.1.1 Global Companion Diagnostics Sales by Region
8.1.2 Global Companion Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche Holdings
9.1.1 Roche Holdings Companion Diagnostics Basic Information
9.1.2 Roche Holdings Companion Diagnostics Product Overview
9.1.3 Roche Holdings Companion Diagnostics Product Market Performance
9.1.4 Roche Holdings Business Overview
9.1.5 Roche Holdings Companion Diagnostics SWOT Analysis
9.1.6 Roche Holdings Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Companion Diagnostics Basic Information
9.2.2 Abbott Laboratories Companion Diagnostics Product Overview
9.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
9.2.4 Abbott Laboratories Business Overview
9.2.5 Abbott Laboratories Companion Diagnostics SWOT Analysis
9.2.6 Abbott Laboratories Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Companion Diagnostics Basic Information
9.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
9.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
9.3.4 Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Agilent Technologies
9.4.1 Agilent Technologies Companion Diagnostics Basic Information
9.4.2 Agilent Technologies Companion Diagnostics Product Overview
9.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
9.4.4 Agilent Technologies Business Overview
9.4.5 Agilent Technologies Recent Developments
9.5 Life Technologies
9.5.1 Life Technologies Companion Diagnostics Basic Information
9.5.2 Life Technologies Companion Diagnostics Product Overview
9.5.3 Life Technologies Companion Diagnostics Product Market Performance
9.5.4 Life Technologies Business Overview
9.5.5 Life Technologies Recent Developments
9.6 GE Healthcare
9.6.1 GE Healthcare Companion Diagnostics Basic Information
9.6.2 GE Healthcare Companion Diagnostics Product Overview
9.6.3 GE Healthcare Companion Diagnostics Product Market Performance
9.6.4 GE Healthcare Business Overview
9.6.5 GE Healthcare Recent Developments
9.7 Agendia
9.7.1 Agendia Companion Diagnostics Basic Information
9.7.2 Agendia Companion Diagnostics Product Overview
9.7.3 Agendia Companion Diagnostics Product Market Performance
9.7.4 Agendia Business Overview
9.7.5 Agendia Recent Developments
9.8 Qiagen
9.8.1 Qiagen Companion Diagnostics Basic Information
9.8.2 Qiagen Companion Diagnostics Product Overview
9.8.3 Qiagen Companion Diagnostics Product Market Performance
9.8.4 Qiagen Business Overview
9.8.5 Qiagen Recent Developments
9.9 Genomic Health
9.9.1 Genomic Health Companion Diagnostics Basic Information
9.9.2 Genomic Health Companion Diagnostics Product Overview
9.9.3 Genomic Health Companion Diagnostics Product Market Performance
9.9.4 Genomic Health Business Overview
9.9.5 Genomic Health Recent Developments
9.10 Myriad Genetics
9.10.1 Myriad Genetics Companion Diagnostics Basic Information
9.10.2 Myriad Genetics Companion Diagnostics Product Overview
9.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
9.10.4 Myriad Genetics Business Overview
9.10.5 Myriad Genetics Recent Developments
9.11 Advanced Cell Diagnostics
9.11.1 Advanced Cell Diagnostics Companion Diagnostics Basic Information
9.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
9.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
9.11.4 Advanced Cell Diagnostics Business Overview
9.11.5 Advanced Cell Diagnostics Recent Developments
9.12 Danaher
9.12.1 Danaher Companion Diagnostics Basic Information
9.12.2 Danaher Companion Diagnostics Product Overview
9.12.3 Danaher Companion Diagnostics Product Market Performance
9.12.4 Danaher Business Overview
9.12.5 Danaher Recent Developments
9.13 Applied Proteomics
9.13.1 Applied Proteomics Companion Diagnostics Basic Information
9.13.2 Applied Proteomics Companion Diagnostics Product Overview
9.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
9.13.4 Applied Proteomics Business Overview
9.13.5 Applied Proteomics Recent Developments
10 Companion Diagnostics Market Forecast by Region
10.1 Global Companion Diagnostics Market Size Forecast
10.2 Global Companion Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Companion Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
10.2.4 South America Companion Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Companion Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2025-2030)
11.1.2 Global Companion Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Companion Diagnostics by Type (2025-2030)
11.2 Global Companion Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings